 | • レポートコード：QYR9ST06502 • 出版社/出版日：QYResearch / 2019年9月5日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、膀胱がん臨床試験の世界市場について調査・分析し、膀胱がん臨床試験の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（CTスキャン、磁気共鳴イメージング（MRI）、骨スキャン、胸部X線）、用途別（膀胱鏡検査、生検、尿細胞診、イメージングテスト）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の膀胱がん臨床試験市場動向 ・主要企業別マーケットシェア ・膀胱がん臨床試験の種類別市場規模2014-2019 （CTスキャン、磁気共鳴イメージング（MRI）、骨スキャン、胸部X線） ・膀胱がん臨床試験の用途別市場規模2014-2019 （膀胱鏡検査、生検、尿細胞診、イメージングテスト） ・膀胱がん臨床試験の北米市場：主要企業・種類別/用途別市場規模 ・膀胱がん臨床試験のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・膀胱がん臨床試験の中国市場：主要企業・種類別/用途別市場規模 ・膀胱がん臨床試験の日本国内市場：主要企業・種類別/用途別市場規模 ・膀胱がん臨床試験の東南アジア市場：主要企業・種類別/用途別市場規模 ・膀胱がん臨床試験のインド市場：主要企業・種類別/用途別市場規模 ・膀胱がん臨床試験の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Lilly TrialGuide、Merck Clinical Trials、Bladder Cancer、Pfizer、Bayer AG） ・膀胱がん臨床試験の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Bladder Cancer Clinical trials are research studies that involve people. The clinical trials on this list are for bladder cancer treatment. … This randomized phase III trial studies how well pembrolizumab works in treating patients with bladder cancer that has spread from where it started to nearby tissue or lymph nodes.In 2018, the global Bladder Cancer Clinical Trials market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Bladder Cancer Clinical Trials status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Bladder Cancer Clinical Trials development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Lilly TrialGuide
Merck Clinical Trials
Bladder Cancer
Pfizer
Bayer AG
…
Market segment by Type, the product can be split into
CT Scan
Magnetic Resonance Imaging (MRI)
Bone Scan
Chest X-ray
Market segment by Application, split into
Cystoscopy
Biopsy
Urine cytology
Imaging Tests
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Bladder Cancer Clinical Trials status, future forecast, growth opportunity, key market and key players.
To present the Bladder Cancer Clinical Trials development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Bladder Cancer Clinical Trials are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Bladder Cancer Clinical Trials Market Size Growth Rate by Type (2014-2025)
1.4.2 CT Scan
1.4.3 Magnetic Resonance Imaging (MRI)
1.4.4 Bone Scan
1.4.5 Chest X-ray
1.5 Market by Application
1.5.1 Global Bladder Cancer Clinical Trials Market Share by Application (2019-2025)
1.5.2 Cystoscopy
1.5.3 Biopsy
1.5.4 Urine cytology
1.5.5 Imaging Tests
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Bladder Cancer Clinical Trials Market Size
2.2 Bladder Cancer Clinical Trials Growth Trends by Regions
2.2.1 Bladder Cancer Clinical Trials Market Size by Regions (2019-2025)
2.2.2 Bladder Cancer Clinical Trials Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Bladder Cancer Clinical Trials Market Size by by Players
3.1.1 Global Bladder Cancer Clinical Trials Revenue by by Players (2014-2019)
3.1.2 Global Bladder Cancer Clinical Trials Revenue Market Share by by Players (2014-2019)
3.1.3 Global Bladder Cancer Clinical Trials Market Concentration Ratio (CR5 and HHI)
3.2 Bladder Cancer Clinical Trials Key Players Head office and Area Served
3.3 Key Players Bladder Cancer Clinical Trials Product/Solution/Service
3.4 Date of Enter into Bladder Cancer Clinical Trials Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Bladder Cancer Clinical Trials Market Size by Type (2014-2019)
4.2 Global Bladder Cancer Clinical Trials Market Size by Application (2014-2019)
5 North America
5.1 North America Bladder Cancer Clinical Trials Market Size (2014-2019)
5.2 Bladder Cancer Clinical Trials Key Players in North America
5.3 North America Bladder Cancer Clinical Trials Market Size by Type
5.4 North America Bladder Cancer Clinical Trials Market Size by Application
6 Europe
6.1 Europe Bladder Cancer Clinical Trials Market Size (2014-2019)
6.2 Bladder Cancer Clinical Trials Key Players in Europe
6.3 Europe Bladder Cancer Clinical Trials Market Size by Type
6.4 Europe Bladder Cancer Clinical Trials Market Size by Application
7 China
7.1 China Bladder Cancer Clinical Trials Market Size (2014-2019)
7.2 Bladder Cancer Clinical Trials Key Players in China
7.3 China Bladder Cancer Clinical Trials Market Size by Type
7.4 China Bladder Cancer Clinical Trials Market Size by Application
8 Japan
8.1 Japan Bladder Cancer Clinical Trials Market Size (2014-2019)
8.2 Bladder Cancer Clinical Trials Key Players in Japan
8.3 Japan Bladder Cancer Clinical Trials Market Size by Type
8.4 Japan Bladder Cancer Clinical Trials Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Bladder Cancer Clinical Trials Market Size (2014-2019)
9.2 Bladder Cancer Clinical Trials Key Players in Southeast Asia
9.3 Southeast Asia Bladder Cancer Clinical Trials Market Size by Type
9.4 Southeast Asia Bladder Cancer Clinical Trials Market Size by Application
10 India
10.1 India Bladder Cancer Clinical Trials Market Size (2014-2019)
10.2 Bladder Cancer Clinical Trials Key Players in India
10.3 India Bladder Cancer Clinical Trials Market Size by Type
10.4 India Bladder Cancer Clinical Trials Market Size by Application
11 Central & South America
11.1 Central & South America Bladder Cancer Clinical Trials Market Size (2014-2019)
11.2 Bladder Cancer Clinical Trials Key Players in Central & South America
11.3 Central & South America Bladder Cancer Clinical Trials Market Size by Type
11.4 Central & South America Bladder Cancer Clinical Trials Market Size by Application
12 International Players Profiles
12.1 Lilly TrialGuide
12.1.1 Lilly TrialGuide Company Details
12.1.2 Company Description and Business Overview
12.1.3 Bladder Cancer Clinical Trials Introduction
12.1.4 Lilly TrialGuide Revenue in Bladder Cancer Clinical Trials Business (2014-2019))
12.1.5 Lilly TrialGuide Recent Development
12.2 Merck Clinical Trials
12.2.1 Merck Clinical Trials Company Details
12.2.2 Company Description and Business Overview
12.2.3 Bladder Cancer Clinical Trials Introduction
12.2.4 Merck Clinical Trials Revenue in Bladder Cancer Clinical Trials Business (2014-2019)
12.2.5 Merck Clinical Trials Recent Development
12.3 Bladder Cancer
12.3.1 Bladder Cancer Company Details
12.3.2 Company Description and Business Overview
12.3.3 Bladder Cancer Clinical Trials Introduction
12.3.4 Bladder Cancer Revenue in Bladder Cancer Clinical Trials Business (2014-2019)
12.3.5 Bladder Cancer Recent Development
12.4 Pfizer
12.4.1 Pfizer Company Details
12.4.2 Company Description and Business Overview
12.4.3 Bladder Cancer Clinical Trials Introduction
12.4.4 Pfizer Revenue in Bladder Cancer Clinical Trials Business (2014-2019)
12.4.5 Pfizer Recent Development
12.5 Bayer AG
12.5.1 Bayer AG Company Details
12.5.2 Company Description and Business Overview
12.5.3 Bladder Cancer Clinical Trials Introduction
12.5.4 Bayer AG Revenue in Bladder Cancer Clinical Trials Business (2014-2019)
12.5.5 Bayer AG Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Bladder Cancer Clinical Trials Key Market Segments
Table Key Players Bladder Cancer Clinical Trials Covered
Table Global Bladder Cancer Clinical Trials Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer CT Scan Figures
Table Key Players of CT Scan
Figuer Magnetic Resonance Imaging (MRI) Figures
Table Key Players of Magnetic Resonance Imaging (MRI)
Figuer Bone Scan Figures
Table Key Players of Bone Scan
Figuer Chest X-ray Figures
Table Key Players of Chest X-ray
Table Global Bladder Cancer Clinical Trials Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Bladder Cancer Clinical Trials Market Share by Application in 2018 & 2025
Figure Cystoscopy Case Studies
Figure Biopsy Case Studies
Figure Urine cytology Case Studies
Figure Imaging Tests Case Studies
Figure Bladder Cancer Clinical Trials Report Years Considered
Figure Global Bladder Cancer Clinical Trials Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Bladder Cancer Clinical Trials Market Size by Regions 2019-2025 (Million US$)
Table Global Bladder Cancer Clinical Trials Market Size by Regions 2019-2025 (Million US$)
Table Global Bladder Cancer Clinical Trials Market Share by Regions 2014-2019
Figure Global Bladder Cancer Clinical Trials Market Share by Regions 2014-2019
Figure Global Bladder Cancer Clinical Trials Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Bladder Cancer Clinical Trials Revenue by by Players (2014-2019) (Million US$)
Table Global Bladder Cancer Clinical Trials Market Share by by Players (2014-2019)
Figure Global Bladder Cancer Clinical Trials Market Share by by Players in 2018
Table Global Bladder Cancer Clinical Trials by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Bladder Cancer Clinical Trials Product/Solution/Service
Table Date of Enter into Bladder Cancer Clinical Trials Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Bladder Cancer Clinical Trials Market Size by Type (2014-2019) (Million US$)
Table Global Bladder Cancer Clinical Trials Market Size Share by Type (2014-2019)
Figure Global Bladder Cancer Clinical Trials Market Size Market Share by Type (2014-2019)
Table Global Bladder Cancer Clinical Trials Market Size by Application (2014-2019) (Million US$)
Table Global Bladder Cancer Clinical Trials Market Size Share by Application (2014-2019)
Figure Global Bladder Cancer Clinical Trials Market Size Market Share by Application (2014-2019)
Figure Global Bladder Cancer Clinical Trials Revenue Market Share by Application in 2018
Figure North America Bladder Cancer Clinical Trials Market Size 2014-2019 (Million US$)
Table North America Key Players Bladder Cancer Clinical Trials Revenue (2018-2019) (Million US$)
Table North America Key Players Bladder Cancer Clinical Trials Market Share (2018-2019)
Table North America Bladder Cancer Clinical Trials Market Size by Type 2014-2019 (Million US$)
Table North America Bladder Cancer Clinical Trials Market Share by Type 2014-2019
Table North America Bladder Cancer Clinical Trials Market Size by Application 2014-2019 (Million US$)
Table North America Bladder Cancer Clinical Trials Market Share by Application 2014-2019
Figure Europe Bladder Cancer Clinical Trials Market Size 2014-2019 (Million US$)
Table Europe Key Players Bladder Cancer Clinical Trials Revenue (2018-2019) (Million US$)
Table Europe Key Players Bladder Cancer Clinical Trials Market Share (2018-2019)
Table Europe Bladder Cancer Clinical Trials Market Size by Type 2014-2019 (Million US$)
Table Europe Bladder Cancer Clinical Trials Market Share by Type 2014-2019
Table Europe Bladder Cancer Clinical Trials Market Size by Application 2014-2019 (Million US$)
Table Europe Bladder Cancer Clinical Trials Market Share by Application 2014-2019
Figure China Bladder Cancer Clinical Trials Market Size 2014-2019 (Million US$)
Table China Key Players Bladder Cancer Clinical Trials Revenue (2018-2019) (Million US$)
Table China Key Players Bladder Cancer Clinical Trials Market Share (2018-2019)
Table China Bladder Cancer Clinical Trials Market Size by Type 2014-2019 (Million US$)
Table China Bladder Cancer Clinical Trials Market Share by Type 2014-2019
Table China Bladder Cancer Clinical Trials Market Size by Application 2014-2019 (Million US$)
Table China Bladder Cancer Clinical Trials Market Share by Application 2014-2019
Figure Japan Bladder Cancer Clinical Trials Market Size 2014-2019 (Million US$)
Table Japan Key Players Bladder Cancer Clinical Trials Revenue (2018-2019) (Million US$)
Table Japan Key Players Bladder Cancer Clinical Trials Market Share (2018-2019)
Table Japan Bladder Cancer Clinical Trials Market Size by Type 2014-2019 (Million US$)
Table Japan Bladder Cancer Clinical Trials Market Share by Type 2014-2019
Table Japan Bladder Cancer Clinical Trials Market Size by Application 2014-2019 (Million US$)
Table Japan Bladder Cancer Clinical Trials Market Share by Application 2014-2019
Figure Southeast Asia Bladder Cancer Clinical Trials Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Bladder Cancer Clinical Trials Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Bladder Cancer Clinical Trials Market Share (2018-2019)
Table Southeast Asia Bladder Cancer Clinical Trials Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Bladder Cancer Clinical Trials Market Share by Type 2014-2019
Table Southeast Asia Bladder Cancer Clinical Trials Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Bladder Cancer Clinical Trials Market Share by Application 2014-2019
Figure India Bladder Cancer Clinical Trials Market Size 2014-2019 (Million US$)
Table India Key Players Bladder Cancer Clinical Trials Revenue (2018-2019) (Million US$)
Table India Key Players Bladder Cancer Clinical Trials Market Share (2018-2019)
Table India Bladder Cancer Clinical Trials Market Size by Type 2014-2019 (Million US$)
Table India Bladder Cancer Clinical Trials Market Share by Type 2014-2019
Table India Bladder Cancer Clinical Trials Market Size by Application 2014-2019 (Million US$)
Table India Bladder Cancer Clinical Trials Market Share by Application 2014-2019
Figure Central & South America Bladder Cancer Clinical Trials Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Bladder Cancer Clinical Trials Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Bladder Cancer Clinical Trials Market Share (2018-2019)
Table Central & South America Bladder Cancer Clinical Trials Market Size by Type 2014-2019 (Million US$)
Table Central & South America Bladder Cancer Clinical Trials Market Share by Type 2014-2019
Table Central & South America Bladder Cancer Clinical Trials Market Size by Application 2014-2019 (Million US$)
Table Central & South America Bladder Cancer Clinical Trials Market Share by Application 2014-2019
Table Lilly TrialGuide Company Details
Table Lilly TrialGuide Revenue in Bladder Cancer Clinical Trials Business 2014-2019 (Million US$)
Figure Lilly TrialGuide Revenue Growth Rate in Bladder Cancer Clinical Trials Business (2014-2019)
Table Lilly TrialGuide Recent Development
Table Merck Clinical Trials Company Details
Table Merck Clinical Trials Revenue in Bladder Cancer Clinical Trials Business 2014-2019 (Million US$)
Figure Merck Clinical Trials Revenue Growth Rate in Bladder Cancer Clinical Trials Business (2014-2019)
Table Merck Clinical Trials Recent Development
Table Bladder Cancer Company Details
Table Bladder Cancer Revenue in Bladder Cancer Clinical Trials Business 2014-2019 (Million US$)
Figure Bladder Cancer Revenue Growth Rate in Bladder Cancer Clinical Trials Business (2014-2019)
Table Bladder Cancer Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Bladder Cancer Clinical Trials Business 2014-2019 (Million US$)
Figure Pfizer Revenue Growth Rate in Bladder Cancer Clinical Trials Business (2014-2019)
Table Pfizer Recent Development
Table Bayer AG Company Details
Table Bayer AG Revenue in Bladder Cancer Clinical Trials Business 2014-2019 (Million US$)
Figure Bayer AG Revenue Growth Rate in Bladder Cancer Clinical Trials Business (2014-2019)
Table Bayer AG Recent Development
Table Global Bladder Cancer Clinical Trials Market Size by Regions (Million US$) 2019-2025
Figure Global Bladder Cancer Clinical Trials Market Size Share by Regions (2019-2025)
Figure Global Bladder Cancer Clinical Trials Market Size Share by Regions in 2025
Figure North America Bladder Cancer Clinical Trials Market Size Forecast (2019-2025)(Million USD)
Figure Europe Bladder Cancer Clinical Trials Market Size Forecast (2019-2025)(Million USD)
Figure China Bladder Cancer Clinical Trials Market Size Forecast (2019-2025)(Million USD)
Figure Japan Bladder Cancer Clinical Trials Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Bladder Cancer Clinical Trials Market Size Forecast (2019-2025)(Million USD)
Figure India Bladder Cancer Clinical Trials Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Bladder Cancer Clinical Trials Market Size Forecast (2019-2025)(Million USD)
Table Global Bladder Cancer Clinical Trials Market Size by Product (2019-2025) (Million US$)
Figure Global Bladder Cancer Clinical Trials Market Size by Product (2019-2025)
Figure Global Bladder Cancer Clinical Trials Market Size by Product in 2025
Table Global Bladder Cancer Clinical Trials Market Size by Application (2019-2025) (Million US$)
Figure Global Bladder Cancer Clinical Trials Market Size by Application (2019-2025)
Figure Global Bladder Cancer Clinical Trials Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
臨床試験管理システムの世界市場：市場規模・現状・予測 A Clinical Trial Management System (CTMS) is a software system used by biotechnology and pharmaceutical industries to manage clinical trials in clinical research. The system maintains and manages planning, performing and reporting functions, along with participant contact information, tracking deadl…- 膀胱がん治療の世界市場：市場規模・現状・予測 The bladder is an organ located in the lower abdominal region near the pelvic bones and acts as a reservoir of urine. A bladder cancer is characterized by the abnormal cell growth in the bladder, which impairs the proper functioning of urinary system. Majority of bladder cancer develops in the inner…
- 磁気共鳴画像の世界市場：インサイト・予測 Intraoperative magnetic resonance imaging (iMRI) refers to an operating room configuration that enables surgeons to image the patient via an MRI scanner while the patient is undergoing surgery, particularly brain surgery. iMRI reduces the risk of damaging critical parts of the brain and helps confir…
- 磁気共鳴画像（MRI）機器の世界市場：インサイト・予測 Magnetic resonance imaging (MRI) is a medical imaging technique used in radiology to form pictures of the anatomy and the physiological processes of the body in both health and disease. MRI scanners use strong magnetic fields, magnetic field gradients, and radio waves to generate images of the organ…
- 子宮頸が診断検査の世界市場：市場規模・現状・予測 Cervical cancer is a cancer arising from the cervix. It is due to the abnormal growth of cells that have the ability to invade or spread to other parts of the body.In 2018, the global Cervical Cancer Diagnostic Tests market size was xx million US$ and it is expected to reach xx million US$ by the en…